Bartira Bergmann-Rossi

Rio De Janeiro, RJ 21941902, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.

Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.

Journal: Pharmaceutics

Published: March 01, 2026

Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.

Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.

Journal: Pharmaceutics

Published: January 31, 2025

Local necrosis induced by intralesional treatment with amphotericin B- deoxycholate.

Local necrosis induced by intralesional treatment with amphotericin B- deoxycholate.

Journal: Acta tropica

Published: January 15, 2025

Simple accessible clemastine fumarate analogues as effective antileishmanials.

Simple accessible clemastine fumarate analogues as effective antileishmanials.

Journal: RSC medicinal chemistry

Published: December 17, 2024

Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection.

Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection.

Journal: Vaccines

Published: August 21, 2024

Intranasal delivery of LaAg vaccine improves immunity of aged mice against visceral Leishmaniasis.

Intranasal delivery of LaAg vaccine improves immunity of aged mice against visceral Leishmaniasis.

Journal: Acta tropica

Published: December 02, 2023

Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.

Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.

Journal: Archiv der Pharmazie

Published: August 09, 2023

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control.

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control.

Journal: Frontiers in cellular and infection microbiology

Published: March 23, 2023

In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis.

In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis.

Journal: Pharmaceutics

Published: November 04, 2022

Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice.

Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice.

Journal: Vaccines

Published: June 28, 2022

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy.

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy.

Journal: Frontiers in cellular and infection microbiology

Published: April 06, 2022

Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum.

Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum.

Journal: Frontiers in immunology

Published: February 27, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026